Manufacturing and Capabilities
Subscribe to Manufacturing and Capabilities

The Lead

Capsugel unveils new spray-dried dispersion commercial manufacturing facility

July 1, 2015 8:31 am | Capsugel | News | Comments

Capsugel announced that it has completed construction of a new pharmaceutical spray-dried dispersion (SDD) commercial manufacturing facility at its site in Bend, Ore. The completion represents the final phase of a two-year, $25 million investment....

NanoSphere unveils cannabinoids delivery system

June 18, 2015 11:38 am | News | Comments

NanoSphere Health Sciences is the first and only patent-pending nanoparticle delivery system for...

Pharmaceutical industry venture capital jumps in 2014

June 18, 2015 11:32 am | by Andy Szal, Digital Reporter | News | Comments

During the first 11 months of 2014, the industry saw $15.3 billion in venture capital compared...

Teva and Microchips Biotech partner on digital drug delivery

June 18, 2015 11:11 am | by Business Wire | News | Comments

“The microchip-based implant is truly at the intersection of digital technology and medicine and...

View Sample

FREE Email Newsletter

Arrowhead Gold to acquire Bio Therapeutic Molecules

June 18, 2015 11:08 am | News | Comments

Pursuant to the agreement, Arrowhead will acquire all shares of BTMI from the BTMI shareholders in exchange for 41.5 million common shares of Arrowhead.

Pancreatic cancer treatment pipeline dominated by early-stage development

June 17, 2015 12:05 pm | by GBI Research | News | Comments

While the pancreatic cancer treatment pipeline contains 447 therapeutics in active development across all phases, compared to 209 currently-marketed products, almost 75 percent of therapies are in Phase I or earlier.

Acura partners with Bayer on methamphetamine technology

June 17, 2015 12:00 pm | by Marketwired | News | Comments

Methamphetamine is a highly addictive drug and its production can be highly flammable.


Report ranks Abilify as top-selling drug

June 17, 2015 11:54 am | by Andy Szal, Digital Reporter | News | Comments

The antipsychotic medication for treatment of depression, bipolar disorder and schizophrenia totaled $7.2 billion in sales between June 2013 and June 2014.

Greengro to develop cannabis products with Native American tribes

June 17, 2015 11:46 am | News | Comments

Greengro was recently featured on Forbes list of "hottest marijuana companies" and continues to gain momentum.

Botox maker Allergan adds 'double-chin' drug with $2.1B deal

June 17, 2015 11:32 am | by The Associated Press | News | Comments

Botox maker Allergan Plc. is buying Kythera Biopharmaceuticals for about $2.1 billion, adding a drug that destroys fat cells and eliminates the cosmetic condition referred to as "double chin".

Pharma pipeline value jumps to $493B

June 16, 2015 11:26 am | by Business Wire | News | Comments

Prescription drug sales are forecasted to grow nearly 5% annually over the next five years.

BDI Pharma reports year-to-date revenues up 37%

June 16, 2015 11:12 am | by PR Newswire | News | Comments

One driver for the company's success is the increased emphasis on strategic partnerships with manufacturers.


Deloitte report: Open R&D models increase chances for late-stage success

June 15, 2015 12:02 pm | by PR Newswire | News | Comments

Deloitte's report suggests that biopharmaceutical companies could have greater success if they collaborate with other organizations — even competitors — as part of an open innovation approach to research and development.

New England Biolabs announces plans for GMP manufacturing

June 12, 2015 11:16 am | News | Comments

The plans include the construction of a new 30,000 square foot, state-of-the-art, fully GMP-compliant cleanroom facility.

Walgreens recalls bottles of women's multivitamins

June 12, 2015 11:11 am | by The Associated Press | News | Comments

Walgreens Boots Alliance, Inc. is recalling a line of women's multivitamins because the packaging is not child-resistant.

Novartis gains FDA approval for childhood blood disorder drug

June 12, 2015 11:08 am | by PRNewswire | News | Comments

ITP affects as many as 5 in 100,000 children each year and is characterized by a low platelet count.

Carna announces collaboration with J&J

June 11, 2015 11:22 am | by Business Wire | News | Comments

Carna Biosciences today announced a worldwide licensing agreement with Janssen Biotech to further develop and commercialize compounds from one of Carna Bioscience’s small molecule protein kinase inhibitor programs.


New Hemp Distribution Business

June 10, 2015 11:12 am | by PRNewswire | News | Comments

The new Sipp Industries Hemp unit will have large-volume hemp ingredients available, including toasted hemp seeds, hulled hemp seeds, hemp protein powder, cold-pressed hemp oil, and purely refined hemp oil.

Quotient delivers breakthrough first-in-human program for Corcept

June 10, 2015 10:40 am | by Quotient Clinical | News | Comments

The program focused on a next generation selective glucocorticoid receptor antagonist in development for the treatment of Cushing’s syndrome and certain cancers.

Vetter Completes Chicago Expansion

June 10, 2015 10:26 am | by Vetter | News | Comments

The CDMO unveiled initiatives that include additional staff for daily clinical manufacturing operations, as well as the doubling of capacities for performing visual inspection and in-process control.

BioPharmaSpec opens new lab to provide characterization services to the biopharmaceutical market

June 9, 2015 11:25 am | by Business Wire | News | Comments

"The demand for our characterization services from North and South America has also been strong," said BioPharmaSpec Founder and President Professor Howard R. Morris.

J&J opens new schizophrenia project

June 9, 2015 11:20 am | by PR Newswire | News | Comments

The project will create a new forum for collaborative analysis of Janssen's clinical trial data with data available from the National Institutes of Health (NIH) about schizophrenia.

AM-Pharma receives FDA and EMA orphan drug designation to treat hypophosphatasia

June 9, 2015 11:13 am | by Business Wire | News | Comments

RecAP is currently in Phase II development for testing the potential treatment of acute kidney injury, with the potential to be developed for hypophosphatasia.

Seattle Genetics, Unum Therapeutics enter cancer collaboration

June 8, 2015 11:28 am | by Business Wire | News | Comments

Seattle Genetics has a substantial portfolio of cancer targets and tumor-specific monoclonal antibodies from which programs will be selected for the collaboration.

Stempeutics receives rare patent from Japan for stem cell drug

June 8, 2015 11:22 am | by PR Newswire | News | Comments

The novelty covers the method of preparing master cell banks, working cell banks and the final therapeutic product "Stempeucel" based on the novel pooling technology.

NIH suspends experimental drug production

June 5, 2015 6:20 am | by Associated Press | News | Comments

Thursday's suspension leaves about 250 people in 46 NIH studies waiting to hear when they will receive other experimental treatments.

CEO: Pfizer doubles share of drug market for breast cancer

June 4, 2015 11:52 am | by Andy Szal, Digital Reporter | News | Comments

Promising trial results for a new drug designed to treat aggressive breast cancer helped Pfizer double its share of that market, according to CEO Ian Read.

Teva looks to raise stake in Mylan following takeover bid

June 3, 2015 5:21 pm | by Andy Szal, Digital Reporter | News | Comments

The ongoing spat between generic pharmaceutical rivals Teva and Mylan shows no signs of slowing down.

TWi gets FDA approval for Intuniv generic

June 3, 2015 10:57 am | by PR Newswire | News | Comments

TWi Pharmaceuticals announced it received final approval from the FDA for its Guanfacine HCl ER tablet.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.